Brazilian CRO Chooses US-Based AmeriStart to Promote Clinical Research Services to the American Market

SAO PAULO, Brazil & CHARLOTTE, N.C.--(BUSINESS WIRE)--AmeriStart announced today that it has signed a sales, marketing, and business development services contract with Eurotrials, a leading international clinical research organization that specializes in conducting clinical studies in Portugal and Brazil. AmeriStart will promote Eurotrials’ considerable clinical research capabilities to the growing North American pharmaceutical and biotechnology market.

“Our team of experienced physicians and clinicians has conducted clinical studies for many of the top American pharmaceutical companies.  Now, with a representative office and AmeriStart’s organizational support, we hope to expand and improve our standing in the US marketplace.”

“Eurotrials provides local capabilities in Brazil and Latin America with the full support and oversight of their founding office in Portugal.  Brazil in particular is a key market for drug developers who need access to patient populations and ultimately, the Brazilian consumer,” stated Rui Melo, Executive Director of Eurotrials, from their headquarters in Portugal.

“Our team of experienced physicians and clinicians has conducted clinical studies for many of the top American pharmaceutical companies.  Now, with a representative office and AmeriStart’s organizational support, we hope to expand and improve our standing in the US marketplace.”

AmeriStart CEO Jim Worrell noted, “Eurotrials has world-class experience and access to patients in Brazil in the key therapeutic areas of diabetes, oncology, and cardiovascular disease.  Because Eurotrials is a well-respected and leading CRO in Brazil, they are often able to navigate a shorter path through Brazil’s regulatory requirements and start a clinical trial sooner than you might expect. Eurotrials has the added benefit of a second operational center in Portugal for multi-center trials that require European data.  They are a one-stop shop for Latin America and Southern Europe.”

Eurotrials is the latest addition to the AmeriStart portfolio of world-class Contract Research Organizations (CROs) and other service providers to the Life Science industry.

Further information on Eurotrials’ Phase 2 - 4 clinical capabilities can be found online at www.eurotrials.com

About AmeriStart

From headquarters in Charlotte, NC, AmeriStart helps foreign companies enter and succeed in the competitive US marketplace. AmeriStart provides sales, marketing, and strategic business development services that help companies overcome cultural, language and market barriers to ramp their sales quickly. For more information, contact David Worrell ([e-mail]) or see www.AmeriStart.com.

About Eurotrials

Eurotrials, established in 1995, is a full service Contract Research Organization offering regulatory and clinical trial services for Pharmaceutical and Biotech sponsors from locations in Portugal and Brazil.